Amphastar Pharmaceuticals Inc (AMPH) Stock
Fundamentals
Recent news

3 Generic Drug Stocks to Watch Amid Improving Industry Trends
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
AMPH

New Strong Sell Stocks for August 14th
New Strong Sell Stocks for August 14th
AMPH

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
AMPH

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates
AMPH
Technicals
Analyst Ratings
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

3 Generic Drug Stocks to Watch Amid Improving Industry Trends
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
AMPH

New Strong Sell Stocks for August 14th
New Strong Sell Stocks for August 14th
AMPH

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
AMPH

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates
AMPH

Amphastar Pharmaceuticals Q2 Earnings Call Highlights
Amphastar Pharmaceuticals Q2 Earnings Call Highlights
AMPH

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
AMPH

Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply
Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply
AMPH

New Strong Sell Stocks for June 23rd
New Strong Sell Stocks for June 23rd
AMPH

Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
AMPH

Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
AMPH
About Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Ziping Luo Ph.D. | Chairman of the Board, Chief Scientist & COO | 1950 |
| Dr. Yongfeng Zhang Ph.D. | Co-Founder, President, CEO, Chief Scientific Officer & Director | 1947 |
| Mr. William J. Peters M.B.A. | CFO, Executive VP of Finance, Treasurer & Director | 1968 |
| Mr. Jacob Liawatidewi M.B.A. | Executive VP of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director | 1974 |
| Mr. Rong Zhou M.S. | Senior EVP of Production & EVP of Scientific Affairs | 1959 |
| Mr. Dan Dischner M.B.A. | Senior Vice President of Human Resources & Corporate Communication | — |
| Tony Marrs M.B.A., M.P.H., M.S. | Executive VP of Regulatory Affairs & Clinical Operations | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
Technicals
What the experts say
4 Wall Street Analyst Ratings
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -1.0 | -3.5 | +3.6 | +17.3 | ||||||||
| 2022 | +0.1 | +12.3 | +30.9 | -5.2 | +5.2 | -7.6 | +5.8 | -20.0 | -5.4 | +8.8 | -5.7 | -6.7 |
| 2023 | +7.3 | +4.1 | +2.6 | -6.2 | +19.0 | +27.3 | +5.3 | -12.1 | -15.7 | -1.0 | +23.9 | +6.8 |
| 2024 | -14.3 | -12.9 | -5.0 | -5.0 | +0.6 | -5.3 | +0.5 | |||||
| 2026 | -27.7 | -6.8 | +8.5 | -13.8 | +9.6 | -0.8 | +11.4 | +13.8 |



